Merck's Keytruda likely to benefit from 'celebrity effect' after Jimmy Carter declared free of cancer

Former President Jimmy Carter has been declared free of cancer after receiving Merck's ($MRK) Keytruda and radiation therapy for his metastasized melanoma, and research shows that Merck is likely to get a boost in sales as a result. A number of studies have documented a proven celebrity effect in healthcare. One study showed after journalist Katy Couric had an on-air colonoscopy, there was a 21% increase in colorectal screenings the next month. Singer Kylie Minogue's breast cancer diagnosis was later linked to mammography screening increases of 40% in Australia. More from FiercePharmaMarketing

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.